The "Del17p/p53 MM CLL Test" is a specialized diagnostic test offered by DNA Labs UAE, designed to detect deletions in chromosome 17p, which includes the TP53 gene, in patients with multiple myeloma (MM) or chronic lymphocytic leukemia (CLL). These genetic abnormalities are associated with a more aggressive disease course and poorer prognosis. Identifying patients with these mutations can significantly influence treatment decisions and strategies, as they may not respond well to certain therapies and might benefit from more aggressive or alternative treatments.
The test cost is 1050 AED and involves collecting a blood or bone marrow sample from the patient, which is then analyzed using advanced genetic testing techniques to identify the presence of the del17p mutation and alterations in the p53 gene. The results from this test provide critical information that helps healthcare providers tailor treatment plans to the specific genetic profile of the patient's disease, aiming for more effective management and improved outcomes.
DNA Labs UAE, where this test is conducted, is equipped with state-of-the-art facilities and employs highly skilled professionals to ensure accurate and reliable testing services. This test represents an important tool in the precision medicine approach to treating hematologic malignancies, highlighting the role of genetic insights in optimizing patient care.
The Delta Beta-Thalassaemia Mutation Screening Test is a specialized genetic test offered by DNA Labs UAE, designed to identify mutations associated with Delta Beta-Thalassemia, a rare blood disorder. This condition results from deletions or mutations in the delta and beta globin genes, leading to reduced or absent production of the delta and beta globin chains, components crucial for hemoglobin formation. Hemoglobin is the protein in red blood cells responsible for oxygen transport throughout the body. Abnormalities in its structure can lead to various health issues, including anemia, fatigue, and more severe complications if left undiagnosed or untreated.
The screening test is crucial for early detection, allowing for appropriate management and counseling for affected individuals and their families. It involves collecting a blood sample from the patient, which is then analyzed using advanced molecular techniques to identify specific genetic mutations associated with the condition.
DNA Labs UAE offers this important test at a cost of 1050 AED. The lab is equipped with state-of-the-art technology and staffed by professionals with expertise in genetic testing and analysis, ensuring accurate and reliable results. Early detection through the Delta Beta-Thalassaemia Mutation Screening Test can significantly improve the quality of life for individuals with the condition by enabling tailored treatments and interventions.
DiGeorge Syndrome FISH (Fluorescence In Situ Hybridization) Test is a specialized diagnostic procedure designed to identify DiGeorge Syndrome, a genetic disorder caused by the deletion of a segment of chromosome 22. This condition can lead to a wide range of developmental issues, including heart defects, immune system problems, and facial abnormalities. The FISH test is a powerful tool that enables precise detection of the genetic anomaly associated with DiGeorge Syndrome by using fluorescent probes that bind to specific parts of the chromosome to highlight the presence or absence of genetic material.
At DNA Labs UAE, the DiGeorge Syndrome FISH Test is available for patients who may exhibit symptoms of the syndrome or have a family history suggesting a genetic risk. The test cost is set at 1050 AED, reflecting the advanced technology and expertise required to conduct this sophisticated genetic analysis. The process involves collecting a sample of the patient's blood, which is then processed in the laboratory where the DNA is examined for the specific chromosomal deletion associated with the syndrome. Results from this test can provide crucial information for diagnosis, allowing healthcare providers to offer appropriate treatment and support for affected individuals and their families.
The E2A ALL Test, offered at DNA Labs UAE for a cost of 1050 AED, is a comprehensive diagnostic tool designed to detect the presence of the E2A-PBX1 fusion gene, which is commonly associated with Acute Lymphoblastic Leukemia (ALL). This genetic anomaly is a result of a translocation between chromosomes 1 and 19, leading to the formation of a hybrid gene that can influence the growth and development of white blood cells, potentially causing leukemia. The test is crucial for the accurate diagnosis and subsequent treatment planning for patients suspected of having ALL. Conducted in the state-of-the-art facilities of DNA Labs UAE, the E2A ALL Test utilizes advanced molecular techniques to ensure precise results, aiding healthcare professionals in making informed decisions about patient care.
The FGFR1 test is a specialized genetic analysis designed to detect mutations in the FGFR1 gene, which can be indicative of various medical conditions, including skeletal disorders, certain types of cancer, and developmental syndromes. This test is crucial for individuals who may be at risk due to family history or those presenting symptoms that suggest an FGFR1 gene mutation. By identifying mutations in this gene, healthcare providers can offer targeted treatment options, make accurate prognoses, and advise on family planning.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the FGFR1 test at DNA Labs UAE is 1050 AED. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab for the presence of mutations in the FGFR1 gene. Results from this test can provide invaluable information for patient care and management, guiding both medical interventions and lifestyle adjustments to mitigate the impact of conditions associated with FGFR1 mutations.
The FGFR3IgH MM Test is a specialized diagnostic assay conducted at DNA Labs UAE, designed to identify specific genetic abnormalities associated with multiple myeloma, a type of blood cancer. This test focuses on detecting translocations and mutations in the FGFR3 gene and its interaction with the IgH gene, which are critical markers for diagnosing and understanding the prognosis of the disease. By analyzing the genetic material from a patient's blood or bone marrow sample, the FGFR3IgH MM Test can provide valuable information that aids in tailoring personalized treatment strategies for individuals with multiple myeloma. The cost of the test is 1050 AED, reflecting the sophisticated technology and expertise required to perform this advanced genetic analysis. DNA Labs UAE, where this test is conducted, is equipped with state-of-the-art facilities and employs highly skilled professionals to ensure accurate and reliable results.
The FROZEN-1 Test, available at DNA Labs UAE for a cost of 1050 AED, is a specialized diagnostic tool designed to assess specific health markers or genetic conditions. While the exact nature of the FROZEN-1 Test could encompass a range of possibilities from fertility assessments to genetic predispositions for certain diseases, DNA Labs UAE is known for utilizing cutting-edge technology and methodologies to ensure accurate and reliable results. Clients opting for this test at DNA Labs UAE can expect professional service, detailed analysis, and comprehensive support in interpreting the results. This test is an example of the advanced healthcare solutions accessible to individuals seeking personalized medical insights in the United Arab Emirates.
The HbE Hemoglobin E Mutation Screening Test is a specialized genetic assay conducted to detect the presence of the Hemoglobin E (HbE) mutation, a variant of the hemoglobin gene. This mutation is one of the common causes of beta-thalassemia, a blood disorder that reduces the production of hemoglobin. Hemoglobin is the protein in red blood cells that carries oxygen throughout the body. The presence of HbE mutation can lead to various health issues, including mild to severe anemia, depending on whether a person inherits one or two copies of the mutated gene.
This screening test is particularly important for individuals of Southeast Asian, Indian, or Middle Eastern descent, where the HbE mutation is more prevalent. It is also recommended for couples planning to have children, as it can help assess the risk of passing the condition to their offspring.
Conducted at DNA Labs UAE, the test involves collecting a small blood sample from the individual. The laboratory uses advanced genetic analysis techniques to identify the presence of the HbE mutation. The cost of the HbE Hemoglobin E Mutation Screening Test at DNA Labs UAE is 1050 AED. The results of this test can provide crucial information for the management of potential health issues related to the HbE mutation, enabling individuals and healthcare providers to take appropriate preventive or therapeutic measures.
The Hepatitis-B Virus (HBV) Qualitative PCR Test is a highly sensitive diagnostic procedure used to detect the presence of HBV DNA in a patient's blood. This molecular testing method employs Polymerase Chain Reaction (PCR) technology to amplify and identify even minute quantities of viral DNA, allowing for the early detection of HBV infection. This test is crucial for diagnosing acute or chronic hepatitis B infections, monitoring the effectiveness of treatment, and determining the need for therapeutic adjustments.
Performed at DNA Labs UAE, a reputable facility known for its advanced diagnostic services, the HBV Qualitative PCR Test is conducted by experienced professionals who ensure accuracy and reliability of results. The test cost is set at 1050 AED, reflecting the sophisticated technology and expertise involved in conducting the analysis. Patients seeking this test can expect a straightforward procedure involving a blood sample, with results providing critical insights into their HBV status, thus facilitating timely and appropriate medical interventions.
The HLA-B*1502 Genotyping Carbamazepine Test is a specialized genetic test conducted to identify the presence of the HLA-B*1502 allele in individuals. This allele is significantly associated with an increased risk of developing Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which are severe skin reactions, in response to the administration of carbamazepine, a medication commonly used for treating epilepsy, trigeminal neuralgia, and bipolar disorder. The test is particularly recommended for individuals of Asian descent, including South Asians, due to a higher prevalence of the HLA-B*1502 allele in these populations.
Performed at DNA Labs UAE, a leading facility in genetic testing, the HLA-B*1502 Genotyping Carbamazepine Test ensures precision and reliability in results. The test is priced at 1050 AED, reflecting the sophisticated technology and expertise involved in conducting genetic assessments. Identifying the presence of the HLA-B*1502 allele enables healthcare providers to make informed decisions regarding the prescription of carbamazepine, potentially preventing life-threatening drug reactions. This test is a critical tool in personalized medicine, allowing for the tailoring of medical treatments to individual genetic profiles, thereby enhancing patient safety and treatment efficacy.
